复星医药
(600196)
| 流通市值：484.71亿 | | | 总市值：611.44亿 |
| 流通股本：21.18亿 | | | 总股本：26.72亿 |
| 报告期 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 13,693,590,965.39 | 13,047,681,296.61 | 14,885,381,738.28 | 15,473,168,152.5 |
| 应收票据及应收账款 | 7,668,228,759.14 | 7,852,682,255.59 | 8,882,651,870.96 | 7,870,449,543.93 |
| 其中：应收票据 | 24,492,488.4 | 23,985,890.15 | 14,707,012.97 | 38,959,696.72 |
| 应收账款 | 7,643,736,270.74 | 7,828,696,365.44 | 8,867,944,857.99 | 7,831,489,847.21 |
| 应收款项融资 | 642,568,580.95 | 688,483,420.18 | 388,967,254.5 | 654,717,514.64 |
| 预付款项 | 884,582,172.88 | 979,554,954.08 | 853,027,246.27 | 1,350,645,866.71 |
| 其他应收款合计 | 626,657,270.84 | 578,255,833.27 | 550,294,776.95 | 719,835,116.25 |
| 应收股利 | - | 14,750,826.36 | - | 19,678,020.08 |
| 存货 | 7,537,767,765.75 | 7,961,906,175.37 | 7,866,866,611.85 | 7,630,095,350.02 |
| 合同资产 | 145,887,291.75 | - | - | - |
| 其他流动资产 | 704,789,708.23 | 626,802,256.16 | 569,099,051.22 | 478,258,518.47 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 33,792,568,948.62 | 34,914,164,504.44 | 36,851,027,973.8 | 35,179,941,530.99 |
| 非流动资产: | | | | |
| 长期应收款 | 85,322,818.08 | 79,238,173.73 | 88,683,770.79 | 84,107,793.16 |
| 长期股权投资 | 23,919,398,947.82 | 23,940,919,369.13 | 23,906,573,124.38 | 23,095,630,777.71 |
| 其他权益工具投资 | 52,774,220.89 | 62,213,369.66 | 52,257,281.7 | 17,762,394.18 |
| 其他非流动金融资产 | 1,040,114,413.33 | 1,112,412,203.91 | 1,083,198,522.75 | 2,369,612,958.83 |
| 固定资产 | 15,129,371,156.29 | 13,474,545,893.36 | 12,058,309,417.74 | 10,251,417,082.85 |
| 在建工程 | 4,938,281,247.38 | 5,636,105,599.08 | 5,678,988,935.38 | 5,528,706,501.87 |
| 使用权资产 | 2,171,744,487.74 | 941,633,687.09 | 900,414,966.42 | 851,386,635.13 |
| 无形资产 | 13,482,016,130.59 | 13,093,205,414.39 | 13,114,517,413.02 | 12,585,063,914.61 |
| 开发支出 | 3,896,108,184.77 | 3,531,195,707.44 | 3,514,826,442.47 | 3,291,580,242.13 |
| 商誉 | 10,851,999,207.39 | 11,004,154,946.29 | 11,059,457,872.24 | 10,260,335,039.33 |
| 长期待摊费用 | 778,805,942.86 | 528,520,787.47 | 549,084,482.56 | 542,158,222.1 |
| 递延所得税资产 | 624,470,612.53 | 449,260,982.23 | 457,421,109.99 | 429,652,907.33 |
| 其他非流动资产 | 2,706,628,495.16 | 1,999,673,658.59 | 2,827,927,832.62 | 2,892,019,391.57 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 79,677,035,864.83 | 75,853,079,792.37 | 75,291,661,172.06 | 72,199,433,860.8 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 113,469,604,813.45 | 110,767,244,296.81 | 112,142,689,145.86 | 107,379,375,391.79 |
| 流动负债: | | | | |
| 短期借款 | 14,728,454,129.15 | 15,433,493,833.15 | 16,621,171,833.65 | 14,012,819,200.1 |
| 应付票据及应付账款 | 6,159,618,701.32 | 6,259,769,956.61 | 6,398,619,477.59 | 6,637,989,229.64 |
| 其中：应付票据 | 652,252,423.59 | 665,284,406.18 | 595,733,841.06 | 832,042,279.22 |
| 应付账款 | 5,507,366,277.73 | 5,594,485,550.43 | 5,802,885,636.53 | 5,805,946,950.42 |
| 合同负债 | 1,200,496,066.44 | 1,264,365,084.06 | 1,210,488,086.02 | 1,073,749,398.44 |
| 应付职工薪酬 | 1,978,115,885.93 | 1,628,196,707.34 | 1,496,218,089.1 | 1,135,746,685.21 |
| 应交税费 | 536,965,065.37 | 765,717,365.27 | 820,651,925.7 | 872,053,638.79 |
| 其他应付款合计 | 4,202,172,433.33 | 4,142,967,669.55 | 5,509,011,191.09 | 4,962,627,508.31 |
| 应付股利 | - | 21,111,041.46 | - | 33,579,965.75 |
| 一年内到期的非流动负债 | 4,826,597,231.71 | 4,905,257,302.75 | 4,658,678,721.34 | 3,678,048,083.99 |
| 其他流动负债 | 125,164,024.57 | 106,529,733.71 | 103,964,295.85 | 95,046,744.44 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 33,757,583,537.82 | 34,506,297,652.44 | 36,818,803,620.34 | 32,468,080,488.92 |
| 非流动负债: | | | | |
| 长期借款 | 13,504,923,111.26 | 12,225,867,713.1 | 11,677,280,063.05 | 11,851,681,250.08 |
| 应付债券 | - | - | - | 499,547,964.85 |
| 租赁负债 | 2,049,589,366.84 | 814,838,276.82 | 760,883,290.6 | 737,928,680.29 |
| 长期应付款 | 507,764,019.67 | 450,728,393.92 | 387,686,803.15 | 346,629,665.7 |
| 长期应付职工薪酬 | 141,475,527.3 | 30,715,060.8 | 118,969,035.92 | 11,948,531.78 |
| 递延收益 | 639,398,945.8 | 606,844,348.48 | 619,120,655.47 | 591,353,848.74 |
| 递延所得税负债 | 3,445,190,578.09 | 3,494,082,300.04 | 3,625,411,735.21 | 3,340,460,904.44 |
| 其他非流动负债 | 2,807,419,290.39 | 2,655,510,796.56 | 2,685,620,007.78 | 2,484,029,434.13 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 23,095,760,839.35 | 20,278,586,889.72 | 19,874,971,591.18 | 19,863,580,280.01 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 56,853,344,377.17 | 54,784,884,542.16 | 56,693,775,211.52 | 52,331,660,768.93 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 2,672,398,711 | 2,672,528,211 | 2,672,156,611 | 2,672,156,611 |
| 资本公积 | 16,853,454,175.22 | 16,955,730,215.89 | 16,955,705,855.04 | 16,968,469,974.41 |
| 减:库存股 | 41,928,227.94 | 61,166,170 | 53,254,806 | 53,254,806 |
| 其他综合收益 | -1,300,090,249.71 | -1,012,301,118.4 | -972,683,110.13 | -1,384,106,481.65 |
| 盈余公积 | 2,958,415,919.58 | 2,952,929,442.2 | 2,952,929,442.2 | 2,952,929,442.2 |
| 未分配利润 | 24,542,511,219.9 | 24,411,655,688.44 | 23,905,160,208.99 | 24,236,965,778.39 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 45,684,761,548.05 | 45,919,376,269.13 | 45,460,014,201.1 | 45,393,160,518.35 |
| 少数股东权益 | 10,931,498,888.23 | 10,062,983,485.52 | 9,988,899,733.24 | 9,654,554,104.51 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 56,616,260,436.28 | 55,982,359,754.65 | 55,448,913,934.34 | 55,047,714,622.86 |
| 负债和股东权益合计 | 113,469,604,813.45 | 110,767,244,296.81 | 112,142,689,145.86 | 107,379,375,391.79 |
| 公告日期 | 2024-03-27 | 2023-10-31 | 2023-08-30 | 2023-04-29 |
| 审计意见(境内) | 标准无保留意见 | | | |